Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
TWAPF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Relative Strength
TWAPF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Earnings Growth
YoY
Current
Estimates
Q3.23
+62%
0.3
vs 0.19
Q4.23
+707%
0.66
vs -0.11
Q1.24
+2318%
0.62
vs 0.03
Q2.24
+4%
0.69
vs 0.67
Q3.24
-50%
0.15
vs 0.3
Q4.24
N/A
NA
vs 0.66
Q1.25
-2%
0.61
vs 0.62
Q2.25
-49%
0.35
vs 0.69
Q3.25
+41407%
62.18
vs 0.15
Q4.25
N/A
76.08
vs NA
Sales Growth
YoY
Current
Estimates
Q3.23
+17%
52.8B vs 45.1B
Q4.23
+22%
60.9B vs 49.9B
Q1.24
-13%
59.6B vs 68.5B
Q2.24
+15%
62.6B vs 54.5B
Q3.24
+15%
60.8B vs 52.8B
Q4.24
+15%
70.3B vs 60.9B
Q1.25
+10%
65.9B vs 59.6B
Q2.25
+4%
65.1B vs 62.6B
Q3.25
+9%
66.5B vs 60.8B
Q4.25
+11%
78.1B vs 70.3B
Return on Equity
QoQ
Q1.23
+0%
0
vs -0.01
Q2.23
+3%
0.03
vs 0
Q3.23
+2%
0.02
vs 0.03
Q4.23
+3%
0.03
vs 0.02
Q1.24
+3%
0.03
vs 0.03
Q2.24
+3%
0.03
vs 0.03
Q3.24
+1%
0.01
vs 0.03
Q4.24
+5%
0.05
vs 0.01
Q1.25
+3%
0.03
vs 0.05
Q2.25
+1%
0.01
vs 0.03
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
Quote Panel
Key Metrics
Forecast
343%2026-Revenue
579%2026-EPS
380%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
OTC
Pre-market 18.87$2.04 (12.12%)
Relative Strenght
Volume Buzz
3451%
Earning Acce
No
Dist 52w H.
34%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How TWAPF compares to sector?
TWAPF
9x